GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tauriga Sciences Inc (OTCPK:TAUG) » Definitions » PE Ratio

Tauriga Sciences (Tauriga Sciences) PE Ratio : At Loss (As of Jun. 04, 2024)


View and export this data going back to . Start your Free Trial

What is Tauriga Sciences PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-06-04), Tauriga Sciences's share price is $1.0E-5. Tauriga Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.03. Therefore, Tauriga Sciences's PE Ratio for today is At Loss.

Tauriga Sciences's EPS (Diluted) for the three months ended in Dec. 2021 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.03.

As of today (2024-06-04), Tauriga Sciences's share price is $1.0E-5. Tauriga Sciences's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.03. Therefore, Tauriga Sciences's PE Ratio without NRI ratio for today is At Loss.

Tauriga Sciences's EPS without NRI for the three months ended in Dec. 2021 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.03.

Tauriga Sciences's EPS (Basic) for the three months ended in Dec. 2021 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.03.

Back to Basics: PE Ratio


Tauriga Sciences PE Ratio Historical Data

The historical data trend for Tauriga Sciences's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauriga Sciences PE Ratio Chart

Tauriga Sciences Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Tauriga Sciences Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Tauriga Sciences's PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tauriga Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauriga Sciences's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tauriga Sciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Tauriga Sciences's PE Ratio falls into.



Tauriga Sciences PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Tauriga Sciences's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=1.0E-5/-0.025
=-0(At Loss)

Tauriga Sciences's Share Price of today is $1.0E-5.
Tauriga Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Tauriga Sciences  (OTCPK:TAUG) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Tauriga Sciences PE Ratio Related Terms

Thank you for viewing the detailed overview of Tauriga Sciences's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauriga Sciences (Tauriga Sciences) Business Description

Traded in Other Exchanges
N/A
Address
4 Nancy Court, Suite 4, Wappingers Falls, New York, NY, USA, 12590
Tauriga Sciences Inc is a revenue-generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. The firm has entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD-infused chewing gum product has been branded under Tauri-Gum. The company commenced sales of Peach-Lemon and Black Currant CBG Gum. It operates in two segments: Tauri-gum division consists of all retail, wholesale, and e-commerce product sales of CBD/CBG Tauri-Gum, Tauri-Gummies, and other CBD/CBG products. Pharma segment includes research and development of the company's FDA IND application for Phase II Trial of its proposed pharmaceutical-grade version of Tauri-Gum.
Executives
James V Rosati director C/O AVADIM HEALTH, INC., 81 THOMPSON STREET, ASHEVILLE NC 28803
Chris Sferruzzo director 220 KUHNE ROAD, SOUTHBURY CT 06488
Kevin Patrick Lacey officer: Chief Financial Officer 701, AMHEARST CT, FRANKLIN TN 37064
Thomas James Graham director 9622 WEST GRAND RIVER AVE, GRAND LEDGE MI 48837
Keith Berman director 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
David L Wolitzky director 100 BLEECKER STREET, NEW YORK NY 10012
Ghalia Lahlou officer: Chief Financial Officer 3465 COTE DES NEIGES, #91, MONTREAL, QC A8 H3H1T7
Stella M. Sung director, officer: Chief Operating Officer 13208 SUNSET POINT WAY, SAN DIEGO CA 92130
Hingge Hsu director 39 OLD RIDGEBURY ROAD, SUITE C4, DANBURY CT 06810
Michael J Brennan director 9601 BEMAN WOODSWAY, POTOMAC MD 20854
Seth M Shaw director, officer: Chief Executive Officer 55 W 25 STREET, APT 33A, NEW YORK NY 10010
Bacterial Robotics, Llc 10 percent owner PO BOX 30085, CINCINNATI OH 45230
Jason Eric Barkeloo 10 percent owner PO BOX 30085, CINCINNATI OH 45230
Bruce Harmon officer: Chief Financial Officer 316 DEL PRADO BLVD. S., SUITE 204, CAPE CORAL FL 33990